CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 4,600 shares at $4.39 ($20,181)
- 4 Open-market buy President, CEO and Director bought 1,797 shares at $4.44 ($7,979)
- 4 Open-market buy Director bought 1,797 shares at $4.44 ($7,979)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale President, CEO and Director sold 1,500,000 shares at an average $4.40 ($6,606,799)
- 4 Open-market sale Director sold 1,500,000 shares at an average $4.40 ($6,606,799)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13D/A Stake Beneficial Ownership Report
Page 7 of 26 · 506 filings